Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers
The initiative aims to standardize digital pathology through an open-source platform and image management system.
The initiative aims to standardize digital pathology through an open-source platform and image management system.
The FDA has cleared ArteraAI Breast, an AI-based digital pathology tool that provides same-day risk stratification for early-stage, HR-positive, HER2-negative invasive breast cancer.
HistoIndex has partnered with Houston Research Institute and Knowledge Research Center to expand access to AI-driven digital pathology for liver disease diagnostics in Texas and California.
The cloud-based system aims to address the bottleneck of translating raw genomic data into actionable information for clinical laboratories.
Stellaris is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues.
The collaboration pairs AI pathology algorithms with global laboratory infrastructure to help biopharma teams speed up evidence generation and diagnostic launch timelines.